| 2021 | Optimization, validation, and comparison of a rapid method for the quantification of insulin-like growth factor 1 in serum using liquid chromatography–high-resolution mass spectrometry | 이화정 | Article |
| 2004 | P-glycoprotein inhibitory activity of Indonesian medicinal plants in human breast cancer cells | 서은경; 이화정; 한아름 | Article |
| 2007 | P-glycoprotein inhibitory activity of two phenolic compounds, (-)-syringaresinol and tricin from Sasa borealis | 서은경; 이화정; 권영주; 한아름 | Article |
| 2009 | Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats | 이화정 | Article |
| 2019 | Pharmacokinetic Alteration of Paclitaxel by Ferulic Acid Derivative | 박혜영; 이화정; 이정연; 이재옥 | Article |
| 2008 | Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4- (quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug | 신윤용; 이화정; 김대기 | Article |
| 2023 | Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia | 이화정; 이정연; 이재옥 | Article |
| 2009 | Potent modulation of p-glycoprotein activity by naturally occurring phenylbutenoids from zingiber cassumunar | 서은경; 이화정; 한아름 | Article |
| 2012 | Preclinical study of a potent P-glycoprotein and cytochrome P450 enzyme inducer rifampicin changing pharmacokinetic parameters of risperidone and its metabolite, 9-hydroxyrisperidone, using a rat model | 이화정; 이정연 | Article |
| 2021 | Quantification of teicoplanin using the hplc-uv method for clinical applications in critically ill patients in Korea | 이화정; 이정연; 이재옥 | Article |
| 2012 | Quantitative analysis of acetaminophen and its six metabolites in rat plasma using liquid chromatography/tandem mass spectrometry | 이화정 | Article |
| 2011 | Quantitative determination of daumone in rat plasma by liquid chromatography-mass spectrometry | 이화정; 하헌주 | Article |
| 2017 | Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor | 이화정; 권영주 | Article |
| 2018 | Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics | 이화정 | Article |
| 2017 | Sensitization of lung cancer cells by altered dimerization of HSP27 | 이화정; 권영주; 이윤실 | Article |
| 2010 | Simple determination of azasetron in rat plasma by column-switching high-performance liquid chromatography | 이화정 | Article |
| 2016 | Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage | 이화정; 정우진; 창동신 | Article |
| 2006 | Surface-imprinted, thermosensitive, core-shell nanosphere for molecular recognition | 이화정; 정병문 | Article |
| 2011 | Synthesis and biological activity of optically active phenylbutenoid dimers | 서은경; 이화정; 한아름 | Article |
| 2007 | Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity | 유충규; 박혜영; 이상국; 이화정 | Article |
| 2002 | Synthesis of pegylated immunonanoparticles | 이화정 | Article |
| 2020 | Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1H-imidazoles as ALK5 inhibitors | 이화정; 김대기 | Article |
| 2010 | Transforming growth factor-β1 bioassay involving matrix metalloproteinase-2 induction | 이화정 | Article |
| 2009 | Validation of a HeLa Mx2/Luc reporter cell line for the quantification of human type i interferons | 이화정 | Article |
| 2015 | Xanthone analogues as potent modulators of intestinal P-glycoprotein | 이화정; 권영주 | Article |
